The FDA has recently issued a black box warning for Reglan, a drug used to treat acid reflux. This warning came after Reglan and other drugs containing metoclopramide were linked to a neurological disorder known as tardive dyskinesia.
If you or a loved one is experiencing tardive dyskinesia after taking Reglan or the generic equivalent metoclopramide, fill out our free, no obligation case evaluation form.
A side effect of Reglan use, tardive dyskinesia is a neurological syndrome that causes involuntary movements of the face and body extremities. Common symptoms of tardive dyskinesia include rapid eye blinking, lip smacking, grimacing and puckering. Those suffering from tardive dyskinesia may also experience trouble breathing, swallowing, walking and talking. While the Reglan black box warning states that tardive dyskinesia is rare, two studies have determined the syndrome prevails in approximately 27% to 29% of long term Reglan users.
In addition to tardive dyskinesia, Reglan has also been linked to neuroleptic malignant syndrome. Symptoms of neuroleptic malignant syndrome symptoms include fever, changes in blood pressure, muscular rigidity, autonomic dysfunction and sweating. In some cases, neuroleptic malignant syndrome can be fatal and usually results from respiratory, renal or heart failure. Though this syndrome usually develops within the first few weeks of treatment, neuroleptic malignant syndrome can develop at any point during the therapy period.
Other side effects of Reglan include:
There is currently no treatment for tardive dyskinesia. Those suffering from this and other Reglan side effects should contact our Reglan attorneys immediately. At Morgan and Morgan, our Reglan side effect lawyers are determined to make pharmaceutical companies responsible for the side effects of their products. Contact us today.